Most healthcare sales orgs already know the theory: firmographics tell you who could buy, intent tells you who's likely to be looking. The gap between knowing that and actually building a list that survives contact with a quota-carrying rep is where most of these projects quietly fail. Below are the questions worth asking before you commit budget or headcount to this.
Q: Why isn't firmographic filtering alone good enough anymore? It used to be.
Firmographics narrow the universe — bed count, specialty mix, ownership structure, EHR platform, GPO affiliation — but they describe a static state, not a moment. A 400-bed IDN that fits your ICP perfectly might be in year three of a multi-year contract with a competitor, or mid-freeze on capital spending, and the firmographic profile won't tell you that. What's changed isn't that firmographics stopped working; it's that buying committees in healthcare have gotten quieter earlier in the cycle, doing more research anonymously before a single form fill. If your targeting stops at "fits the profile," you're spending the same effort on an account that's dormant as one that's actively evaluating, which is a bad use of a finite sales motion.
Q: What actually counts as a reliable intent signal in a healthcare/industrial B2B context, versus noise?
The honest answer is that most third-party intent data — the kind aggregated from content consumption across ad networks and publisher co-ops — is directionally useful at best and frequently polluted by research-adjacent traffic that has nothing to do with buying intent (a resident reading about a device for a paper, a competitor doing market scans). More reliable signals tend to be closer to the account: hiring patterns for roles that imply a new initiative (a health system posting for a "clinical informatics lead" or a "value-based care director"), procurement or RFP activity if you can get visibility into it, technology install/uninstall signals, and first-party behavior on your own properties. The rule of thumb is that intent signals get more trustworthy the closer they are to observable action and less trustworthy the more they're inferred from aggregated content topics. Treat third-party topic-based intent as a tiebreaker or a prioritization layer, not as a standalone trigger to call.
Q: Isn't this just going to produce a longer list that's harder to act on, not a better one?
That's a fair challenge, and it's the actual failure mode of a lot of "combined" account lists — teams layer intent on top of firmographics and end up with more rows in a spreadsheet, not more clarity. The fix isn't addition, it's subtraction: firmographics should be used to build the eligible universe (the accounts you'd ever want to sell to), and intent should be used almost exclusively to sequence and deprioritize within that universe, not to add accounts back in that failed the firmographic screen. A tighter firmographic filter — genuinely disqualifying accounts that don't fit, not just deprioritizing them — combined with an intent layer that's allowed to demote as well as promote accounts, tends to produce a shorter list that reps actually work, rather than a longer one they triage badly. If the combined list isn't shorter and more confident than either input alone, the model is set up wrong.
Q: How do you handle the fact that healthcare buying committees are genuinely different from a single-threaded SaaS buyer — does intent data even map cleanly onto that?
This is one of the more legitimate structural problems with importing an intent-data playbook wholesale from SaaS. In a hospital or health system, the "account" showing intent signals might be a supply chain analyst doing due diligence for a committee that includes clinical, IT, finance, and compliance stakeholders who never generate any observable digital footprint at all. Intent data at the account level tells you something is stirring, but it's usually blind to where in that committee the interest lives, which means the signal is better used to justify multi-threading outreach across a buying group than to identify a single "hot" contact to call. Practically, this means pairing intent signals with contact-level firmographic data — title, department, tenure — so the trigger prompts a coordinated outreach sequence across three or four roles, not a single rep cold-calling whoever the platform flagged. Skipping this step is a common reason intent-triggered outreach in healthcare underperforms relative to the same tactic in flatter B2B markets.
Q: How often should an account list like this be refreshed, and what breaks if you treat it as a one-time build?
Firmographic data in healthcare decays faster than people expect — M&A activity, EHR migrations, leadership turnover, and facility closures or openings happen continuously, and a list built even two quarters ago will have a meaningful percentage of stale or merged entities. Intent signals decay on a much shorter cycle; a spike that's six weeks old is often just noise by the time a rep gets to it. The practical implication is that the firmographic base should be revalidated on a quarterly-ish cadence at minimum, while the intent layer needs closer to a weekly or biweekly refresh to stay useful for prioritization, and these two cadences should be decoupled in whatever system runs the scoring rather than forced into a single rebuild. Treating this as a one-time list-building project — the way a lot of teams treated file purchases historically — guarantees that by month four, reps are working a list that's actively lying to them about who's in-market.
Q: Given all the caveats, is the ROI on this actually provable, or is it mostly a directional improvement you take on faith?
It's fair to be skeptical here, because clean attribution is genuinely hard — a closed deal six months after an intent spike could just as easily have closed on firmographics alone, and most teams don't run the controlled comparison that would settle the question. What is more provable, and worth measuring instead, is efficiency at the top of the funnel: connect rates, meeting-set rates, and time-to-first-meaningful-conversation on intent-flagged accounts versus firmographic-only accounts of similar profile. In our own work at NPLUS Global helping healthcare-focused sales teams build these lists, the more consistent pattern isn't a dramatic lift in close rate — it's that reps stop wasting cycles on accounts with no live motion, which shows up as capacity, not magic. If a vendor promises you a pipeline lift number without showing you that kind of funnel-stage comparison, that's the number to be skeptical of, not the concept itself.
Ready to see what we can build for your ICP?
Send us your ICP — sample in 2–3 hours, full delivery in 48–72 hours.
Request a free sample →